{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:12:17Z","timestamp":1789737137916,"version":"4.0.1"},"reference-count":45,"publisher":"China Science Publishing & Media Ltd.","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2026,5,1]]},"DOI":"10.3724\/abbs.2026082","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T10:16:38Z","timestamp":1778235398000},"update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":1,"title":["USP18-stabilized ELF3 drives glycolysis and malignant                     progression in lung adenocarcinoma"],"prefix":"10.3724","author":[{"given":"Yu","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeran","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinfen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohe","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixia","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiwei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baihui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weipeng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2026","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"CITATION1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"Siegel RL","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin, 2022, 72: 7-33.","journal-title":"CA Cancer J Clin"},{"key":"CITATION2","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S0140-6736(21)00312-3","volume":"398","author":"Thai AA","year":"2021","unstructured":"Thai AA, Solomon BJ, Sequist LV, Gainor JF, Heist RS. Lung cancer. Lancet, 2021, 398: 535-554.","journal-title":"Lancet"},{"key":"CITATION3","doi-asserted-by":"publisher","first-page":"122637","DOI":"10.1016\/j.lfs.2024.122637","volume":"346","author":"Ju Y","year":"2024","unstructured":"Ju Y, Fang S, Liu L, Ma H, Zheng L. The function of the ELF3 gene and its mechanism in cancers. Life Sci, 2024, 346: 122637.","journal-title":"Life Sci"},{"key":"CITATION4","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/labinvest.2011.186","volume":"92","author":"Oliver JR","year":"2012","unstructured":"Oliver JR, Kushwah R, Hu J. Multiple roles of the epithelium-specific ETS transcription                         factor, ESE-1, in development and disease. Lab Invest, 2012, 92: 320-330.","journal-title":"Lab Invest"},{"key":"CITATION5","doi-asserted-by":"publisher","first-page":"7734","DOI":"10.1111\/jcmm.16654","volume":"25","author":"Huang Y","year":"2021","unstructured":"Huang Y, Zhang X, Zhan J, Yan Z, Chen D, Xue X, Pan X. Bone marrow mesenchymal stem cell-derived exosomal miR-206                         promotes osteoblast proliferation and differentiation in osteoarthritis by                         reducing Elf3. J Cell Mol Medi, 2021, 25: 7734-7745.","journal-title":"J Cell Mol Medi"},{"key":"CITATION6","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41419-020-2598-6","volume":"11","author":"Wang J","year":"2020","unstructured":"Wang J, Shen X, Liu J, Chen W, Wu F, Wu W, Meng Z. High glucose mediates NLRP3 inflammasome activation via                         upregulation of ELF3 expression. Cell Death Dis, 2020, 11: 383.","journal-title":"Cell Death Dis"},{"key":"CITATION7","doi-asserted-by":"publisher","first-page":"4533","DOI":"10.1158\/0008-5472.CAN-12-4537","volume":"73","author":"Longoni N","year":"2013","unstructured":"Longoni N, Sarti M, Albino D, Civenni G, Malek A, Ortelli E, Pinton S. ETS transcription factor ESE1\/ELF3 orchestrates a positive                         feedback loop that constitutively activates NF-\u03baB and drives prostate cancer                         progression. Cancer Res, 2013, 73: 4533-4547.","journal-title":"Cancer Res"},{"key":"CITATION8","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41419-018-0399-y","volume":"9","author":"Zheng L","year":"2018","unstructured":"Zheng L, Xu M, Xu J, Wu K, Fang Q, Liang Y, Zhou S. ELF3 promotes epithelial-mesenchymal transition by protecting                         ZEB1 from miR-141-3p-mediated silencing in hepatocellular carcinoma. Cell Death Dis, 2018, 9: 387.","journal-title":"Cell Death Dis"},{"key":"CITATION9","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/nature12881","volume":"506","author":"Ojesina AI","year":"2014","unstructured":"Ojesina AI, Lichtenstein L, Freeman SS, Pedamallu CS, Imaz-Rosshandler I, Pugh TJ, Cherniack AD. Landscape of genomic alterations in cervical carcinomas. Nature, 2014, 506: 371-375.","journal-title":"Nature"},{"key":"CITATION10","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3233\/CBM-190013","volume":"25","author":"Gondkar K","year":"2019","unstructured":"Gondkar K, Patel K, Krishnappa S, Patil A, Nair B, Sundaram GM, Zea TT. E74 like ETS transcription factor 3 (ELF3) is a negative                         regulator of epithelial- mesenchymal transition in bladder carcinoma. Cancer Biomark, 2019, 25: 223-232.","journal-title":"Cancer Biomark"},{"key":"CITATION11","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1158\/0008-5472.CAN-19-2988","volume":"81","author":"Suzuki M","year":"2021","unstructured":"Suzuki M, Saito-Adachi M, Arai Y, Fujiwara Y, Takai E, Shibata S, Seki M. E74-like factor 3 is a key regulator of epithelial integrity and                         immune response genes in biliary tract cancer. Cancer Res, 2021, 81: 489-500.","journal-title":"Cancer Res"},{"key":"CITATION12","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1089\/jir.2010.0110","volume":"31","author":"Zhang D","year":"2011","unstructured":"Zhang D, Zhang DE. Interferon-stimulated gene 15 and the protein ISGylation system. J Interferon                             Cytokine Res, 2011, 31: 119-130.","journal-title":"J Interferon                             Cytokine Res"},{"key":"CITATION13","doi-asserted-by":"publisher","first-page":"923","DOI":"10.3389\/fchem.2019.00923","volume":"7","author":"Jim\u00e9nez Fern\u00e1ndez D","year":"2020","unstructured":"Jim\u00e9nez Fern\u00e1ndez D, Hess S, Knobeloch KP. Strategies to target ISG15 and USP18 toward therapeutic                         applications. Front Chem, 2020, 7: 923.","journal-title":"Front Chem"},{"key":"CITATION14","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41467-022-35348-5","volume":"14","author":"Arimoto K","year":"2023","unstructured":"Arimoto K, Miyauchi S, Troutman TD, Zhang Y, Liu M, Stoner SA, Davis AG. Expansion of interferon inducible gene pool via USP18 inhibition                         promotes cancer cell pyroptosis. Nat Commun, 2023, 14: 251.","journal-title":"Nat Commun"},{"key":"CITATION15","doi-asserted-by":"publisher","first-page":"110617","DOI":"10.1016\/j.intimp.2023.110617","volume":"122","author":"Ma Z","year":"2023","unstructured":"Ma Z, Xiong Q, Cai S, Ding L, Yin C, Xia H, Liu W. USP18 enhances the resistance of BRAF-mutated melanoma cells to                         vemurafenib by stabilizing cGAS expression to induce cell autophagy. Int                             Immunopharmacol, 2023, 122: 110617.","journal-title":"Int                             Immunopharmacol"},{"key":"CITATION16","doi-asserted-by":"publisher","first-page":"e2444","DOI":"10.1038\/cddis.2016.326","volume":"7","author":"Honke N","year":"2016","unstructured":"Honke N, Shaabani N, Zhang DE, Hardt C, Lang KS. Multiple functions of USP18. Cell Death Dis, 2016, 7: e2444.","journal-title":"Cell Death Dis"},{"key":"CITATION17","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41571-019-0203-7","volume":"16","author":"Li X","year":"2019","unstructured":"Li X, Wenes M, Romero P, Huang SCC, Fendt SM, Ho PC. Navigating metabolic pathways to enhance antitumour immunity and                         immunotherapy. Nat Rev Clin                             Oncol, 2019, 16: 425-441.","journal-title":"Nat Rev Clin                             Oncol"},{"key":"CITATION18","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1002\/1878-0261.12666","volume":"14","author":"Shang R","year":"2020","unstructured":"Shang R, Wang M, Dai B, Du J, Wang J, Liu Z, Qu S. Long noncoding RNA SLC2A1-AS1 regulates aerobic                         glycolysis and progression in hepatocellular carcinoma via inhibiting the                         STAT3\/FOXM1\/GLUT1 pathway. Mol Oncol, 2020, 14: 1381-1396.","journal-title":"Mol Oncol"},{"key":"CITATION19","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.cell.2008.08.021","volume":"134","author":"Hsu PP","year":"2008","unstructured":"Hsu PP, Sabatini DM. Cancer cell metabolism: Warburg and beyond. Cell, 2008, 134: 703-707.","journal-title":"Cell"},{"key":"CITATION20","doi-asserted-by":"publisher","first-page":"144158","DOI":"10.1016\/j.gene.2019.144158","volume":"726","author":"Abbaszadeh Z","year":"2020","unstructured":"Abbaszadeh Z, \u00c7e\u015fmeli S, Biray Avc\u0131 \u00c7\u0131. Crucial players in glycolysis: cancer progress. Gene, 2020, 726: 144158.","journal-title":"Gene"},{"key":"CITATION21","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jdsr.2017.08.003","volume":"54","author":"Kato Y","year":"2018","unstructured":"Kato Y, Maeda T, Suzuki A, Baba Y. Cancer metabolism: new insights into classic characteristics. Jpnese Dent Sci                             Rev, 2018, 54: 8-21.","journal-title":"Jpnese Dent Sci                             Rev"},{"key":"CITATION22","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1002\/1878-0261.12780","volume":"14","author":"Smolle E","year":"2020","unstructured":"Smolle E, Leko P, Stacher\u2010Priehse E, Brcic L, El\u2010Heliebi A, Hofmann L, Quehenberger F. Distribution and prognostic significance of gluconeogenesis and                         glycolysis in lung cancer. Mol Oncol, 2020, 14: 2853-2867.","journal-title":"Mol Oncol"},{"key":"CITATION23","doi-asserted-by":"crossref","unstructured":"The Cancer Genome Atlas Research Network. Comprehensive genomic                         characterization defines human glioblastoma genes and core pathways.                              Nature                          2008, 455:                         1061\u20131068.","DOI":"10.1038\/nature07385"},{"key":"CITATION24","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","volume":"25","author":"Chandrashekar DS","year":"2022","unstructured":"Chandrashekar DS, Karthikeyan SK, Korla PK, Patel H, Shovon AR, Athar M, Netto GJ. UALCAN: an update to the integrated cancer data analysis platform. Neoplasia, 2022, 25: 18-27.","journal-title":"Neoplasia"},{"key":"CITATION25","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1021\/pr501254j","volume":"14","author":"Edwards NJ","year":"2015","unstructured":"Edwards NJ, Oberti M, Thangudu RR, Cai S, McGarvey PB, Jacob S, Madhavan S. The CPTAC data portal: a resource for cancer proteomics research. J Proteome Res, 2015, 14: 2707-2713.","journal-title":"J Proteome Res"},{"key":"CITATION26","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1158\/1541-7786.MCR-20-0579","volume":"19","author":"Liu X","year":"2021","unstructured":"Liu X, Lu Y, Chen Z, Liu X, Hu W, Zheng L, Chen Y. The ubiquitin-specific peptidase USP18 promotes lipolysis, fatty                         acid oxidation, and lung cancer growth. Mol Cancer                             Res, 2021, 19: 667-677.","journal-title":"Mol Cancer                             Res"},{"key":"CITATION27","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1023\/B:BREA.0000010710.51614.2d","volume":"83","author":"Kaplan MH","year":"2004","unstructured":"Kaplan MH, Wang XP, Xu HP, Dosik MH. Partially unspliced and fully spliced ELF3 mRNA, including a new                         Alu element in human breast cancer. Breast                             Cancer Res Treat, 2004, 83: 171-187.","journal-title":"Breast                             Cancer Res Treat"},{"key":"CITATION28","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.3390\/molecules23092191","volume":"23","author":"Luk IY","year":"2018","unstructured":"Luk IY, Reehorst CM, Mariadason JM. ELF3, ELF5, EHF and SPDEF transcription factors in tissue                         homeostasis and cancer. Molecules, 2018, 23: 2191.","journal-title":"Molecules"},{"key":"CITATION29","doi-asserted-by":"publisher","first-page":"e1263","DOI":"10.1038\/cddis.2014.206","volume":"5","author":"Wang JL","year":"2014","unstructured":"Wang JL, Chen ZF, Chen HM, Wang MY, Kong X, Wang YC, Sun TT. Elf3 drives \u03b2-catenin transactivation and associates with poor                         prognosis in colorectal cancer. Cell Death Dis, 2014, 5: e1263.","journal-title":"Cell Death Dis"},{"key":"CITATION30","doi-asserted-by":"publisher","first-page":"3449","DOI":"10.2147\/OTT.S248507","volume":"13","author":"Kong L","year":"2020","unstructured":"Kong L, Liu P, Zheng M, Wang Z, Gao Y, Liang K, Wang H. The miR-1224-5p\/ELF3 axis regulates malignant behaviors of                         pancreatic cancer via PI3K\/AKT\/Notch signaling pathways. Onco Targets Ther, 2020, 13: 3449-3466.","journal-title":"Onco Targets Ther"},{"key":"CITATION31","doi-asserted-by":"publisher","first-page":"570","DOI":"10.3892\/or.2018.6807","volume":"41","author":"Chen H","year":"2018","unstructured":"Chen H, Chen W, Zhang X, Hu L, Tang G, Kong J, Wang Z. E26 transformation (ETS)\u2011specific related transcription factor\u20113                         (ELF3) orchestrates a positive feedback loop that constitutively activates                         the MAPK\/Erk pathway to drive thyroid cancer. Oncol Rep, 2018, 41: 570-578.","journal-title":"Oncol Rep"},{"key":"CITATION32","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/cr.2016.39","volume":"26","author":"Swatek KN","year":"2016","unstructured":"Swatek KN, Komander D. Ubiquitin modifications. Cell Res, 2016, 26: 399-422.","journal-title":"Cell Res"},{"key":"CITATION33","doi-asserted-by":"publisher","first-page":"25377","DOI":"10.1074\/jbc.M111.222760","volume":"286","author":"Duex JE","year":"2011","unstructured":"Duex JE, Comeau L, Sorkin A, Purow B, Kefas B. Usp18 regulates epidermal growth factor (EGF) receptor expression                         and cancer cell survival via microRNA-7. J Biol Chem, 2011, 286: 25377-25386.","journal-title":"J Biol Chem"},{"key":"CITATION34","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1158\/0008-5472.CAN-09-1942","volume":"70","author":"Potu H","year":"2010","unstructured":"Potu H, Sgorbissa A, Brancolini C. Identification of USP18 as an important regulator of the                         susceptibility to IFN-\u03b1 and drug-induced apoptosis. Cancer Res, 2010, 70: 655-665.","journal-title":"Cancer Res"},{"key":"CITATION35","doi-asserted-by":"publisher","first-page":"e3709","DOI":"10.1002\/jgm.3709","volume":"26","author":"Tang N","year":"2024","unstructured":"Tang N, Liu X. USP18 promotes colon adenocarcinoma progression via targeting the                         ERK-MNK signaling pathway. J Gene Med, 2024, 26: e3709.","journal-title":"J Gene Med"},{"key":"CITATION36","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/nrc1478","volume":"4","author":"Gatenby RA","year":"2004","unstructured":"Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis?. Nat Rev Cancer, 2004, 4: 891-899.","journal-title":"Nat Rev Cancer"},{"key":"CITATION37","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.3390\/ijms24032606","volume":"24","author":"Chelakkot C","year":"2023","unstructured":"Chelakkot C, Chelakkot VS, Shin Y, Song K. Modulating glycolysis to improve cancer therapy. Int J Mol Sci, 2023, 24: 2606.","journal-title":"Int J Mol Sci"},{"key":"CITATION38","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1101\/gad.889901","volume":"15","author":"Gottlob K","year":"2001","unstructured":"Gottlob K, Majewski N, Kennedy S, Kandel E, Robey RB, Hay N. Inhibition of early apoptotic events by Akt\/PKB is dependent on                         the first committed step of glycolysis and mitochondrial hexokinase. Genes Dev, 2001, 15: 1406-1418.","journal-title":"Genes Dev"},{"key":"CITATION39","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.2967\/jnumed.108.060780","volume":"50","author":"Ahn KJ","year":"2009","unstructured":"Ahn KJ, Hwang HS, Park JH, Bang SH, Kang WJ, Yun M, Lee JD. Evaluation of the role of hexokinase type II in cellular                         proliferation and apoptosis using human hepatocellular carcinoma cell lines. J Nucl Med, 2009, 50: 1525-1532.","journal-title":"J Nucl Med"},{"key":"CITATION40","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1111\/cas.12238","volume":"104","author":"Sato\u2010Tadano A","year":"2013","unstructured":"Sato\u2010Tadano A, Suzuki T, Amari M, Takagi K, Miki Y, Tamaki K, Watanabe M. HexokinaseII in breast carcinoma: a potent prognostic factor                         associated with hypoxia-inducible factor-1\u03b1 and Ki-67. Cancer Sci, 2013, 104: 1380-1388.","journal-title":"Cancer Sci"},{"key":"CITATION41","doi-asserted-by":"publisher","first-page":"9418","DOI":"10.3390\/ijms25179418","volume":"25","author":"Shin N","year":"2024","unstructured":"Shin N, Lee HJ, Sim DY, Ahn CH, Park SY, Koh W, Khil J. Anti-warburg mechanism of ginsenoside F2 in human cervical cancer                         cells via activation of miR193a-5p and inhibition of                         \u03b2-Catenin\/c-Myc\/Hexokinase 2 signaling axis. Int J Mol Sci, 2024, 25: 9418.","journal-title":"Int J Mol Sci"},{"key":"CITATION42","doi-asserted-by":"publisher","first-page":"112086","DOI":"10.1016\/j.biopha.2021.112086","volume":"145","author":"Zeng Z","year":"2022","unstructured":"Zeng Z, Nian Q, Chen N, Zhao M, Zheng Q, Zhang G, Zhao Z. Ginsenoside Rg3 inhibits angiogenesis in gastric precancerous                         lesions through downregulation of Glut1 and Glut4. Biomed                             Pharmacother, 2022, 145: 112086.","journal-title":"Biomed                             Pharmacother"},{"key":"CITATION43","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.phymed.2018.09.003","volume":"54","author":"Wei X","year":"2019","unstructured":"Wei X, Mao T, Li S, He J, Hou X, Li H, Zhan M. DT-13 inhibited the proliferation of colorectal cancer via                         glycolytic metabolism and AMPK\/mTOR signaling pathway. Phytomedicine, 2019, 54: 120-131.","journal-title":"Phytomedicine"},{"key":"CITATION44","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.bbrc.2015.08.097","volume":"465","author":"Hong SY","year":"2015","unstructured":"Hong SY, Hagen T. 2-Deoxyglucose induces the expression of thioredoxin interacting                         protein (TXNIP) by increasing O-GlcNAcylation-Implications for targeting the                         Warburg effect in cancer cells. Biochem Biophys                             Res Commun, 2015, 465: 838-844.","journal-title":"Biochem Biophys                             Res Commun"},{"key":"CITATION45","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/bjc.2013.391","volume":"109","author":"Golding JP","year":"2013","unstructured":"Golding JP, Wardhaugh T, Patrick L, Turner M, Phillips JB, Bruce JI, Kimani SG. Targeting tumour energy metabolism potentiates the cytotoxicity                         of 5-aminolevulinic acid photodynamic therapy. Br J Cancer, 2013, 109: 976-982.","journal-title":"Br J Cancer"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.sciengine.com\/doi\/pdf\/7E8A2F9EE3E146E187806BB04D4097F8","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2026082","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/doi\/pdf\/7E8A2F9EE3E146E187806BB04D4097F8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T07:15:22Z","timestamp":1780038922000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2026082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":45,"URL":"https:\/\/doi.org\/10.3724\/abbs.2026082","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,1]]}}}